MedTrace Logo

Microdosing ICG for Serial Colonic Perfusion Study During Surgery

NCT06254833 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-12

No results posted yet for this study

Summary

using microdosing of ICG vs regular dosing of ICG for perfusion assessment during surgery

Conditions

  • Perfusion; Complications

Interventions

OTHER

micro dosing of ICG

smaller dose of injection of ICG. All devices used are FDA approved in clinical use.

Sponsors & Collaborators

  • Shanglei Liu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-10-01
Completion
2024-11-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06254833 on ClinicalTrials.gov